Stocks
Arrowhead Pharmaceuticals (ARWR) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 675.3% | 1 078% | 875.6% | 563.3% | 199.8% | 191.4% | |||
| Changes by years, y/y, % | -3 052pp | +403pp | -203pp | -312pp | -363pp | -44.3% | |||
Arrowhead Pharmaceuticals. R&D/CAPEX, %
Arrowhead Pharmaceuticals. R&D/CAPEX, changes, pp
Arrowhead Pharmaceuticals (ARWR) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D/CAPEX, % | 274.1% | 203.3% | 156.3% | 169.7% | 284.7% | 191.4% | ||
| Changes by years, y/y, % | -1 325pp | -554pp | -99pp | -45pp | +11pp | |||
| Changes by quarters, q/q, % | +59pp | -71pp | -47pp | +13pp | +115pp | |||
